Detalhe da pesquisa
1.
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Lancet Infect Dis
; 20(7): 827-838, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325037